Our Portfolio


Featured Projects

Impact of Aging on Lung Tumorigenesis

2021 Emerging Leader Award

Tuomas Tammela, MD, PhD, Memorial Sloan Kettering Cancer Center

Read More

Cellular and Molecular Drivers of Obesity-Associated Breast Cancer

2021 Emerging Leader Award

Paul Cohen, MD, PhD, Rockefeller University

Read More

Targeting Oncogenic Proteoforms Using Tyrosine-Reactive Chemistry

2021 Emerging Leader Award

Ku-Lung (Ken) Hsu, PhD, University of Virginia

Read More

Deciphering Organellar Oxidative Metabolism in Kras-Driven Cancers

2021 Emerging Leader Award

Kıvanç Birsoy, PhD, Rockefeller University

Read More

In vivo Forward Genetic Screens to Identify Immunotherapy Resistance Mechanisms and Synergistic Treatment Combinations for Cancer

2021 Emerging Leader Award

Hao Zhu, MD, Children’s Medical Center Research Institute at UT Southwestern

Read More

Identifying and Targeting 3D Enhancer Hubs that Maintain Cancer Stem Cell Programs

2021 Emerging Leader Award

Effie Apostolou, PhD, Weill Cornell Medicine

Read More

Causes and Consequences of Rapid Cancer Cell Adaptation to MAPK Pathway Inhibitors

2021 Emerging Leader Award

Sabrina Spencer, PhD, University of Colorado Boulder

Read More


All Projects

filter by

Program

Research Area

Cancer Types

Show All

Decoding the Regulatory Network of Tumor Progression in Childhood Ependymoma

ASPIRE Award (2021-Present)

Pablo Gonzalez Cámara, PhD, University of Pennsylvania

Read More

Engineering TILs to Utilize Kynurenine as an Essential Nutrient for Survival in the Tumor Microenvironment

In Partnership with Emerson Collective (2021-Present)

David Hockenbery, MD, Fred Hutchinson Cancer Research Center

Read More

Evolution of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis

The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present)

Johanna Melo-Cardenas, PhD, St. Jude Children’s Research Hospital

Read More

Cell Morphological Modulation of Oncogenic RAS Signaling

Damon Runyon - Mark Foundation Postdoctoral Fellow (2021-Present)

Gabriel Muhire Gihana, PhD, University of Texas Southwestern Medical Center

Read More

Deciphering Immune Cell Heterogeneity and Transcriptomic Changes Associated with CRS Development and Severity in CAR-T Cell Treated Patients

The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present)

Sylvain Simon, PhD, Fred Hutchinson Cancer Research Center

Read More

Evaluating a Novel Collaboration Between NOTCH1 and MLL1 for Improved Targeted Treatments in T-ALL

The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present)

Therese Vu, PhD, University of Colorado Denver

Read More

Characterize the Role of Non-Vesicular Cholesterol Transport in CD8+ T Cell Function

Damon Runyon - Mark Foundation Postdoctoral Fellow (2021-Present)

Yajing Gao, PhD, University of California, Los Angeles

Read More

Induced Proximity for Destabilization of Core Regulatory Factors in Alveolar Rhabdomyosarcoma

ASPIRE Award (2020-Present)

Benjamin Stanton, PhD (Principal), Nationwide Children's Hospital and Jun Qi, PhD, Dana-Farber Cancer Institute

Read More

Molecular Mechanisms of Tumor Progression and Plasticity in Bladder Cancer

Endeavor Award (2020-Present)

Cory Abate-Shen, PhD, and Michael Shen, PhD, Columbia University - Principal Investigators

Read More

Evoking Immune Response Using Phosphorylation-Inducing Chimeric Small Molecules

ASPIRE Award (2020-Present)

Amit Choudhary, PhD, Harvard Medical School

Read More